Actinomycin-D for methotrexate-resistant low-risk gestational trophoblastic neoplasia (GTN)

被引：0
|
作者：
Lurain, J. [1 ]
Schink, J. [2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Prentice Womens Hosp, Chicago, IL 60611 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [31] Validation of the predictive value of modeled hCG decline profiles in low-risk gestational trophoblastic neoplasia (GTN) treated with methotrexate (MTX).
    Freyer, G.
    You, B.
    Harvey, R.
    Golfier, F.
    Mitchell, H.
    Savage, P.
    Tod, M.
    Philip, C.
    Hajri, T.
    Seckl, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] The diagnostics and treatment of low-risk gestational trophoblastic neoplasia (GTN): 42-year experience
    Fulop, Vilmos
    Szigetvari, Ivan
    Szepesi, Janos
    Lahm, Erika
    Vegh, Gyorgy
    Demeter, Janos
    Papai, Zsuzsanna
    Berkowitz, Ross S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1159 - 1165
  • [33] Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Aghajanian, Carol
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 786 - +
  • [34] TREATMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE WITH METHOTREXATE, ACTINOMYCIN-D, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
    LURAIN, JR
    BREWER, JI
    OBSTETRICS AND GYNECOLOGY, 1985, 65 (06) : 830 - 836
  • [35] Comparison of Cost-Effectiveness Between Actinomycin D Versus Methotrexate-Folinic Acid in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Lertkhachonsuk, Arb-aroon
    Hanvoravongchai, Piya
    JOURNAL OF REPRODUCTIVE MEDICINE, 2016, 61 (5-6) : 230 - 234
  • [36] Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia A Randomized Controlled Trial
    Lertkhachonsuk, Arb-aroon
    Israngura, Nathpong
    Wilailak, Sarikapan
    Tangtrakul, Somsak
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 985 - 988
  • [37] Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women
    Hartmann Uberti, Elza Maria
    Fajardo, Maria do Carmo
    Vieira da Cunha, Adriana Gerhardt
    Frota, Sirlene Soares
    Braga, Antonio
    Koehler Ayub, Antonio Celso
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2015, 37 (06): : 258 - 265
  • [38] Comparison of pulsed actinomycin D and 5-day actinomycin D as first-line chemotherapy for low-risk gestational trophoblastic neoplasia
    Mu, Xiyan
    Song, Liang
    Li, Qingli
    Yin, Rutie
    Zhao, Xia
    Wang, Danqing
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 (02) : 225 - 231
  • [39] Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia
    Cyriac, Sanju
    Rajendranath, Rejiv
    Sridevi, Veluswami
    Sagar, Tenali G.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 (01) : 37 - 39
  • [40] Cyclophosphamide, Hydroxyurea, Actinomycin D, Methotrexate, and Vincristine in the Treatment of Gestational Trophoblastic Neoplasia
    Chu, Mandy Man Yee
    Ma, Yaomei
    Tse, Ka Yu
    Chan, Karen Kar Loen
    Ngan, Hextan Yuen Sheung
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (03) : 498 - 503
12345